X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

The 7th U.S. Circuit Court of Appeals ruled Tuesday in favor of the Wisconsin Alumni Research Foundation, which claimed that the drug company Xenon breached their agreement to share licensing fees for a patent covering a cholesterol-lowering enzyme. The 28-page ruling affirms the district court’s award of $300,000 to WARF. But the bigger story is the 7th Circuit’s finding that the contract between WARF and Xenon trumped Xenon’s patent law rights. In an eloquent discussion of the ruling, Dennis Crouch of Patently-O explains that Xenon’s Sidley Austin attorneys had tried to invoke the law of concurrent patent ownership, which generally holds that joint patent owners don’t have to share licensing revenue. But both the district court and the 7th Circuit found that the rule doesn’t apply when the parties have reached an agreement to the contrary. Even if that agreement does not explicitly revoke the law of concurrent patent ownership, the 7th Circuit concluded, the contract holds. “Xenon argues that nothing in the exclusive license agreement explicitly revokes its statutory right to license its interest freely,” wrote Judge Diane Schwerm Sykes for the court. “True, but the agreement’s provision requiring that Xenon pay the [WARF] a share of the fees derived from any sublicense plainly undermines Xenon’s claim that it retained an unfettered right … to transfer its interest in the technology to third parties.” Russell Johnson of Sidley Austin, an attorney for Xenon, was not available for comment. WARF’s attorney, Anthony Tomaselli of Quarles & Brady, did not return a call for comment.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.